Document Title
Patient Package Inserts (prescription drugs). Statement given before the Institute of Medicine.
Author
Moss, James M., MD (presented statement).
Keywords
Drug Prescriptions;Drug Industry;Patient Education
Creation Date
Modified Date
Pages
6
Document
asim_statement_on_prescription_drug_patient_package_inserts_1979.pdf
Adobe Metadata
{"Author":"Moss, James M., MD (presented statement).","Producer":"Acrobat 4.0 Scan Plug-in for Windows\u0000","Creator":"Acrobat 4.0 Capture Plug-in for Windows\u0000","Keywords":"Drug Prescriptions;Drug Industry;Patient Education","ModDate":"2000-08-17T10:56:19-07:00","Abstract":".ASIM's purpose is the continued improvement of patient care. ASIM endorses patients' rights to know about the drugs that are prescribed for them. ASIM has advocated controlled studies of the effects of Patient Package Inserts (PPIs) since 1975. ASIM believes that a more scientific and less Subjective study than those carried out in the past would provide more reliable information about the usefulness of PPIs. In lieu of previous consumer interview studies, ASIM suggests double blind controlled studies. A variety of drugs, diseases, practice situations, and patient populations should be studied. The effects of PPIs on patient compliance deserves the highest priority for continued investigation.","Title":"Patient Package Inserts (prescription drugs). Statement given before the Institute of Medicine.","DocType":"Formal Statement","CreationDate":"2000-08-17T10:54:13-07:00","DateApproved":"1979-02-13","Pages":6}
Document Type
Policy
Year
1979